Blinklab (BB1.AX) Stock Analysis & Winston Score

Blinklab Ltd is a small Australian technology company that makes a smartphone app designed to help detect signs of neurodevelopmental conditions like autism and ADHD in young children. The app works by using a phone's camera to measure how a child's eyes respond to light and sound, turning a simple reflex test into a screening tool. Doctors, clinics, and parents are the main users, and the company sits within the digital health software space. Blinklab earns revenue by licensing its software to healthcare providers and through partnerships with research institutions and health systems. The company operates primarily in Australia but is working to expand into international markets, including Europe and the United States. Its main competitive edge is its patented eye-blink reflex technology, which offers a low-cost, non-invasive alternative to traditional developmental screening methods. The key growth driver is gaining regulatory approvals and clinical adoption in larger markets, while the main risk is that a small company with limited revenue must prove clinical validity to win trust from healthcare systems.